Current Epidemiology and Trends in Meningococcal Disease—United States, 1996–2015
- 8 November 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 66 (8), 1276-1281
- https://doi.org/10.1093/cid/cix993
Abstract
In 2005, meningococcal conjugate vaccine (MenACWY) was recommended for routine use among adolescents aged 11–18 years. This report describes the epidemiologic features of meningococcal disease and trends in meningococcal disease incidence following MenACWY introduction in the United States. Incidence rates and case-fatality ratios by age group and serogroup during 2006–2015 were calculated using data from the National Notifiable Diseases Surveillance System (NNDSS); changes in incidence during this time were evaluated. Additionally, 20-year trends (1996–2015) in age- and race-standardized incidence were examined using data from Active Bacterial Core surveillance (ABCs). During the years 2006–2015, 7,924 cases of meningococcal disease were reported to NNDSS, resulting in an average annual incidence of 0.26 cases per 100,000 population; 14.9% of cases were fatal. Among cases with serogroup information, 2,290 (35.8%) were serogroup B, 1,827 (28.5%) were serogroup Y, 1,457 (22.8%) were serogroup C, 436 (6.8%) were serogroup W, and 392 (6.1%) were other serogroups. The incidence of serogroups A, C, W, and Y combined declined 76% among persons aged 11–20 years from 2006–2010 to 2011–2015 (p<.0001). From 1996-2015, the incidence of meningococcal disease declined among all age groups and predominant serogroups. Declines in meningococcal disease incidence in the United States have been observed among all age groups and predominant serogroups (B, C, and Y). Reductions in the incidence of meningococcal disease due to serogroups A, C, W, and Y among adolescents suggest an impact of the MenACWY vaccine program in this age group.Keywords
This publication has 8 references indexed in Scilit:
- National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2015Mmwr. Morbidity and Mortality Weekly Report, 2016
- Development of Real-Time PCR Methods for the Detection of Bacterial Meningitis Pathogens without DNA ExtractionPLOS ONE, 2016
- Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015Published by Centers for Disease Control MMWR Office ,2015
- Changes inNeisseria meningitidisDisease Epidemiology in the United States, 1998–2007: Implications for Prevention of Meningococcal DiseaseClinical Infectious Diseases, 2010
- Use of Real-Time PCR To Resolve Slide Agglutination Discrepancies in Serogroup Identification of Neisseria meningitidisJournal of Clinical Microbiology, 2004
- Functional Analysis of B144/LST1: A Gene in the Tumor Necrosis Factor Cluster That Induces Formation of Long Filopodia in Eukaryotic CellsExperimental Cell Research, 2001
- Active Bacterial Core Surveillance of the Emerging Infections Program NetworkEmerging Infectious Diseases, 2001
- Epidemic Serogroup B Meningococcal Disease in OregonPublished by American Medical Association (AMA) ,1999